Professional Documents
Culture Documents
Cancer Glycolisis PDF
Cancer Glycolisis PDF
The multistep process of carcinogenesis is often described reported by Warburg in the 1920s3, leading him to the
as occuring by somatic evolution, because it seems for- hypothesis that cancer results from impaired mitochon-
mally analogous to Darwinian processes, wherein pheno- drial metabolism. Although the Warburg hypothesis
typic properties are retained or lost depending on their has proven incorrect, the experimental observations of
contribution to individual fitness. According to this increased glycolysis in tumours even in the presence of
model, traits that are found in invasive cancers must arise oxygen have been repeatedly verified4.
as adaptive mechanisms to environmental proliferative Following Warburgs initial observation, interest in
constraints during carcinogenesis1. Conversely, the com- the metabolic property of cancers has varied over time.
mon appearance of a phenotypic property in cancer pop- Intense investigation in the 1960s was followed by a
ulations is presumptive evidence that it must confer a steep decline concomitant with the widespread applica-
selective growth advantage. tion of newer molecular techniques. The atmosphere of
A curious, but common, property of invasive cancers the day was summarized by Sidney Weinhouse, who
is altered glucose metabolism. Glycolysis literally lysis said Since our perspectives have broadened over the
of glucose first requires the conversion of glucose to years, the burning issues of glycolysis and respiration in
pyruvate (FIG. 1) and then to the waste product lactic cancer now flicker only dimly5.
acid. In most mammalian cells, glycolysis is inhibited by However, interest in tumour metabolism has been
*Departments of Radiology the presence of oxygen, which allows mitochondria to rekindled, mainly because of the widespread clinical
and Applied Mathematics, oxidize pyruvate to CO2 and H2O. This inhibition is application of the imaging technique positron-
University of Arizona, termed the Pasteur effect, after Louis Pasteur, who first emission tomography (PET) using the glucose ana-
Tucson, Arizona 85721, USA.
demonstrated that glucose flux was reduced by the logue tracer 18fluorodeoxyglucose (FdG)68. FdG PET
Departments of Radiology
and Biochemistry and presence of oxygen2. This metabolic versatility of mam- imaging of thousands of oncology patients has
Molecular Biophysics, malian cells is essential for maintenance of energy unequivocally shown that most primary and metasta-
University of Arizona, production throughout a range of oxygen concentra- tic human cancers show significantly increased glucose
Tucson, Arizona 85721, USA. tions. Conversion of glucose to lactic acid in the pres- uptake (FIG. 2). For many cancers, the specificity and
Correspondence to R.A.G.
e-mail: rgatenby@ ence of oxygen is known as aerobic glycolysis or the sensitivity of FdG PET to identify primary and
radiology.arizona.edu Warburg effect. Increased aerobic glycolysis is uniquely metastatic lesions is near 90%9. Sensitivity is lowered
doi:10.1038/nrc1478 observed in cancers. This phenomenon was first because FdG PET has difficulty resolving lesions less
HEXOKINASES Summary
Enzymes that catalyse the
transfer of phosphate from ATP Widespread clinical use of 18fluorodeoxyglucose positron-emission tomography has demonstrated that the glycolytic
to glucose to form glucose-6- phenotype is observed in most human cancers.
phosphate. This is the first
reaction in the metabolism of The concept of carcinogenesis as a process that occurs by somatic evolution clearly implies that common traits of the
glucose and prevents efflux of malignant phenotype, such as upregulation of glycolysis, are the result of active selection processes and must confer a
glucose from the cell. significant, identifiable growth advantage.
Constitutive upregulation of glycolysis is likely to be an adaptation to hypoxia that develops as pre-malignant lesions
HYPOXIA
Refers to a low oxygen level. This grow progressively further from their blood supply. At this stage, the blood supply remains physically separated from
means different levels to the growing cells by an intact basement membrane.
different investigators, but for Increased acid production from upregulation of glycolysis results in microenvironmental acidosis and requires further
radiation biologists hypoxia
adaptation through somatic evolution to phenotypes resistant to acid-induced toxicity.
occurs at levels less than 0.1%
oxygen in the gas phase. Cell populations that emerge from this evolutionary sequence have a powerful growth advantage, as they alter their
Normoxia refers to normal levels environment through increased glycolysis in a way that is toxic to other phenotypes, but harmless to themselves. The
of oxygen (>10%) and anoxia environmental acidosis also facilitates invasion through destruction of adjacent normal populations, degradation of
refers to no oxygen. the extracellular matrix and promotion of angiogenesis.
We propose that the glycolytic phenotype, by conferring a powerful growth advantage, is necessary for evolution of
invasive human cancers.
than 0.8 cm3, and specificity is lowered because other resides at the transport and phosphorylation steps1416.
tissues, notably immune cells, also avidly trap FdG. FdG PET imaging also allows quantitation of glu-
When these limitations are accounted for, it can be rea- cose uptake. These studies have consistently correlated
sonably surmised that virtually all invasive cancers poor prognosis and increased tumour aggressiveness
avidly trap FdG. with increased glucose uptake 17,18. In addition,
The increased glucose uptake imaged with FdG PET hypoxic tumours, which require increased glycolysis
is largely dependent on the rate of glycolysis. FdG to survive, are often1922, but not always23, more inva-
uptake and trapping occurs because of upregulation of sive and metastatic than those with normal oxygen
glucose transporters (notably GLUT1 and GLUT3) and levels. These results demonstrate the clinical impor-
10,11
HEXOKINASES I and II Although metabolic control over tance of glucose metabolism and have moved the gly-
glycolytic rate can be applied at many steps in the gly- colytic phenotype from a laboratory oddity to the
colytic pathway12,13, most studies in cancer support the mainstream of clinical oncology.
hypothesis that control over glycolytic flux primarily Cells derived from tumours typically maintain their
metabolic phenotypes in culture under normoxic condi-
tions, indicating that aerobic glycolysis is constitutively
upregulated through stable genetic or epigenetic
Blood vessel changes. Consistent with the FdG PET results, the gly-
colytic rate in cultured cell lines seems to correlate with
Glucose HbO2 tumour aggressiveness. For example, non-invasive
MCF-7 breast cancer cells have much lower aerobic
glucose consumption rates compared with the highly
Anion invasive MDA-mb-231 breast cancer cell line (FIG. 3).
Glucose O2 exchanger
HCO3 These observations indicate that altered metabo-
H+ lism of glucose by tumours is more than a simple
Glucose 36 ATP Lactate adaptation to HYPOXIA. We suggest that the near-
transporter Mitochondrion universal observation of aerobic glycolysis in invasive
Mono-
human cancers, its persistence even under normoxic
carboxylate H+ conditions and its correlation with tumour aggres-
transporter siveness indicate that the glycolytic phenotype confers
Glucose Lactate
2 ATP a significant proliferative advantage during somatic
Hexokinase evolution of cancer and must, therefore, be a crucial
Glucose-6- Pyruvate
phosphate component of the malignant phenotype.
H+
Sodiumhydrogen At first glance, this hypothesis seems at odds with
exchanger
an evolutionary model of carcinogenesis, because the
proliferative advantage of the glycolytic phenotype is
Figure 1 | Glucose metabolism in mammalian cells. Afferent blood delivers glucose and oxygen not immediately apparent. First, anaerobic metabo-
(on haemoglobin) to tissues, where it reaches cells by diffusion. Glucose is taken up by specific lism of glucose is inefficient it produces only 2 ATP
transporters, where it is converted first to glucose-6-phosphate by hexokinase and then to
pyruvate, generating 2 ATP per glucose. In the presence of oxygen, pyruvate is oxidized to HCO3,
per glucose, whereas complete oxidation produces 38
generating 36 additional ATP per glucose. In the absence of oxygen, pyruvate is reduced to lactate, ATP per glucose (FIG. 1). Second, the metabolic prod-
which is exported from the cell. Note that both processes produce hydrogen ions (H+), which ucts of glycolysis, such as hydrogen ions (H+), cause a
cause acidification of the extracellular space. HbO2, oxygenated haemoglobin. spatially heterogeneous but consistent acidification of
40
lized. This process of diffusion and consumption was
modelled by Krogh as early as 1919 through
reactiondiffusion equations that showed that oxygen 30
pO2 mm Hg
8 affecting substrate use cannot be early events in carcino-
pH
7.0 genesis because they would not confer a selective growth
6
advantage in an environment in which proliferation is
4
6.8 not limited by substrate availability.
2 The evolutionary models show, however, that clonal
6.6 0
expansion of pre-malignant tumour populations is
0 100 200 300 400 eventually limited by substrate availability33, as cell prolif-
Distance (mm) eration, unconstrained by normal tissue interactions,
carries the population increasingly far from its blood
7.0
b supply (see above). In FIG. 5, note the distances between
blood vessels and the necrotic zone of late-stage carci-
noma in situ. Low oxygen concentrations seem to be the
first substrate limitation confronting neoplastic cell pop-
ulations, as reactiondiffusion models and empirical
Extracellular pH
studies have shown that pO2 decline more rapidly with
distance from blood vessels than do glucose levels25,30,35,36.
Although the presence of hypoxia in pre-malignant
in situ lesions has not been measured directly, it can be
inferred from the frequent observation of necrosis in
these lesions and by demonstration of hypoxia-inducible
MDA-MB-435 enzymes such as carbonic anhydrases IX and XII in late-
6.4 stage ductal carcinoma in situ, particularly adjacent to
areas of necrosis37. We suggest that hypoxia in the
Figure 4 | Hyperacidity of tumours. These figures illustrate the
micro- and macro-heterogeneity of pH. a | Tumour interstitial pH penumbral region of pre-malignant tumours produces
and partial pressure of oxygen (pO2) are shown with distance an adaptive landscape that favours a switch to anaerobic
from a vessel wall. These were measured in vivo in MCF-7 breast metabolism, which allows maintenance of metabolic
cancer cells using fluorescent ratio imaging. b | The extracellular activities in the absence of oxygen.
pH of a MDA-MB-435 breast tumour in mice was imaged with A key factor in this adaptive landscape seems to be
the pH indicator IEPA and measured by 1H magnetic-
the exposure of cells near the oxygen diffusion limit to
resonance spectroscopy. Part a reproduced with permission
from REF. 30 (1997) Nature Publishing Group. Part b
an unstable environment due to fluctuations in the
reproduced with permission from REF. 26 (2002) Wiley. haemodynamics of distant blood vessels. Oxichypoxic
cycles in tumours have been measured to occur with
periodicities of minutes38, hours39 or days40. For instance,
phenotypes that adapt to harsh environments (through Gallezs group has recently imaged tumour xenografts
resistance to hypoxia and acid-induced cell toxicity) using a magnetic-resonance imaging (MRI) technique
and successfully compete for scarce resources, such as that is sensitive to oxygenation status41. Analyses showed
oxygen and glucose31,32. that fluctuations in signal intensity (oxygenation)
occurred with discrete periodicities of 1 and 20 cycles
Emergence of the glycolytic phenotype per hour. By contrast, Dewhirst and colleagues used
Evolutionary game theory is a mathematical approach microelectrodes to show periodicities of about 12
that analyses strategy dynamics in adaptation to environ- cycles per minute42. However, it should be noted that
HAEMATOCRIT
mental growth winners in this game proliferate, MRI, although imaging the whole tumour, is insensitive
A measure of the concentration whereas losers become extinct. Recently, this method has to rapid fluctuations, and microelectrode instabilities
of red cells in the blood. A been applied to somatic evolution of the malignant render these electrodes insensitive to slower changes.
reduced haematocrit decreases phenotype33. This analysis showed that proliferation of Nonetheless, all of these studies show that oxygen deliv-
the oxygen-carrying capacity of
the blood.
normal cells is controlled by their interactions with other ery to tumours is inconsistent. These temporal cycles are
cells and the extracellular matrix (ECM), and by the lev- probably due to a range of physiological mechanisms.
VASOMOTION els of growth factors. Importantly, cell proliferation and Relatively rapid oxicanoxic cycles can occur because
Rhythmic oscillations in survival in normal tissue is not constrained by substrate of fluctuations in HAEMATOCRIT43 and VASOMOTION44.
vascular tone caused by local
availability, except under pathological conditions such as Variations occurring over days probably involve VASCULAR
changes in smooth muscle. 45,46
acute vascular occlusion (for example, caused by strokes REMODELLING or cycles of neoangiogenesis and regres-
VASCULAR REMODELLING and myocardial infarcts) or chronic occlusion (as seen in sion due to hypoxia-induced expression of secreted vas-
The active process of altering diabetic ulcers). It follows, therefore, that the earliest cular endothelial growth factor (VEGF), which is an
structure and arrangement in steps in carcinogenesis require alterations in cellular sen- induction and survival factor for new blood vessels40.
blood vessels through cell
growth, cell death, cell migration
sitivity to these normal tissue constraints. So, prolifera- From a bioenergetic standpoint, periodic hypoxia will
and production or degradation tion will follow genetic alterations that reduce sensitivity select for cells in which anaerobic glucose metabolism is
of the extracellular matrix. to growth constraints generated by other cells, the ECM constitutively upregulated, as they would better survive
VEGF
Model
Glucose diffusion limit
O2 diffusion limit
Basement
membrane
Blood vessel
Stroma
Figure 6 | Model for cellenvironment interactions in carcinogenesis. Early carcinogenesis proceeds from normal tissues
through initiation to a hyperplastic state to interstitial neoplasia, progressing to carcinoma in situ. Until this stage, epithelial cancers are
avascular, as shown by histopathology (FIG. 5). Following breakdown of the basement membrane, cells gain access to existing and
newly formed blood and lymphatic vascular routes for metastasis. The stages of tumour growth and their associated physiological
states are diagrammed, showing that progression from one stage to the next is governed by state processes. Normal epithelial cells
(grey) become hyperproliferative (pink) following induction. As they reach the oxygen diffusion limit, they become hypoxic (blue), which
can either lead to cell death (apoptotic cells shown with blebbing) or adaptation of a glycolytic phenotype (green), which allows cells to
survive. As a consequence of glycolysis, lesions become acidotic, which selects for motile cells (yellow) that eventually breach the
basement membrane. As cancer progression proceeds, the mutations in cells increase (nuclei shown as light orange for one mutation
and darker oranges for more mutations). HIF1, hypoxia-inducible factor-1; VEGF, vascular endothelial growth factor.
Multiple cellular pathways might lead to the gly- achieved through multiple mechanisms, including
colytic phenotype, so that altered glucose metabolism oncogene activation or stabilization of transcription
might even result in cells with normal HIF levels. For factors such as HIF1.
example, upregulation of glycolytic enzymes can be
coordinated in response to oxidationreduction Angiogenesis
changes by the Sp1 transcription-factor complex68. We suggest that the glycolytic phenotype evolves in a
GLUT1 can be upregulated directly by MYC13,69 or indi- microenvironment that is avascular; that is, the evolv-
rectly by KRAS70. Interestingly, in this latter study, ing tumour cells remain physically separated from
KRAS activation was only associated with a subset of their blood supply by a basement membrane, as
GLUT1-positive colon cancers, indicating that it is one occurs in in situ tumours. This invokes the diffusion
of several mechanisms to activate glycolysis in this sys- of substrates from the vascularized stroma to the pro-
tem. RAS activation of GLUT1 transcription seems to liferating tumour epithelium. Therefore, even though
be mediated through HIF1 transactivation71. late-stage carcinoma in situ can be characterized as
Hexokinase II can be transcriptionally activated by angiogenic, the tumour does not become vascular-
mutant p53 (REF. 72) or through demethylation of its ized until the basement membrane is breached by an
promoter73. It is also intriguing to note that transfection invasive cell. In fact, there is emerging evidence that
of fibroblasts with H+-ATPase or Na+H+ exchange the glycolytic switch occurs before the angiogenic
raises the intracellular pH, makes them tumorigenic switch; lactic acid has been observed in regions of
and leads to marked increases in glycolysis74,75. These invasive gliomas76,77 that lack vessel permeability, as
alternative systems for upregulating glycolysis are con- shown by the absence of contrast enhancement with
sistent with our basic proposal that the mechanism of MRI78. We do not wish to indicate that angiogenesis
induction is not as important as the induction itself. does not have a role in this process. In fact, it is likely
That is, the glycolytic phenotype is not a secondary that angiogenic factors, such as VEGF, are produced
phenomenon that results from induction of some by the tumour and that this will promote increased
other pathway during carcinogenesis. Rather, it is vascularity within the stroma (FIG. 6). However, these
directly selected because it provides a growth advantage new vessels remain physically separated from the
and acquisition of the glycolytic phenotype might be tumour cells by the basement membrane (see figure 2
CLASTOGENIC in REF. 79). This will not necessarily result in increased are not known, but might involve the metalloproteinases
Describing any substance or substrate delivery through diffusion, as substrate con- and/or cathepsins, which promote the degradation of the
processes that increases centrations in the reactiondiffusion equation are ECM and basement membranes86,87.
alterations in the structure of
unaltered. So, a hallmark of these early cancers is a
chromosomes.
failure of angiogenesis to relieve hypoxia because of Metastasis
GAP JUNCTIONS the physical separation between vessels and the cells So far, we have focused on the role of upregulated gly-
Linked channels through they feed. This can result in a futile cycle of hyperpro- colysis and resistance to extracellular acidosis in adap-
contiguous cell membranes that liferating blood vessels. Once the basement mem- tation to conditions in early pre-malignant lesions and
interconnect the cytoplasm of
adjacent cells and allow direct
brane is breached, the tumour will become vascular in the evolution of invasive primary cancers. However,
exchange of ions and small both by co-opting the pre-existing vessels within the we note that this phenotype might also be crucial in
molecules. stroma and by promoting new vessel growth directly the maturation of metastases as well. Upregulated gly-
into the tumour mass. colysis, evidenced by increased intratumoral lactate
concentrations, is associated with increased incidence
Acidosis and invasion of metastasis in cervical and head and neck cancers88,89.
Although the glycolytic phenotype seems to be the result Furthermore, a correlation between GLUT1 expres-
of adaptation to environmental constraints in pre-malig- sion levels and metalloproteinase expression has also
nant lesions, its persistence in primary and metastatic been reported in metastatic cancers90.
cancers even in conditions of normoxia indicates that it During the process of metastasis, migratory cells
continues to provide a strong selective growth advantage invade the stromal tissue and move to distant sites, lodg-
following malignant progression. We suggest, in fact, that ing in pre-capillary arterioles and capillaries91,92. These
acquisition of the glycolytic phenotype is required for cells probably also experience periodic hypoxic or anoxic
invasive tumour growth. episodes as they proliferate and occlude the intravascular
A constitutive and persistent increase in glycolysis space. Therefore, the end stage of the metastasis sequence
results in acute and chronic acidification of the local envi- will also favour cells that are glycolytic and resistant to
ronment. Indeed, numerous studies have shown that the hypoxia- or acid-induced apoptosis. Any selective advan-
extracellular pH of human and animal tumours is consis- tage is important, as the success rate of metastasis is low.
tently acidic and can reach pH values approaching 6.0 For example, in a typical lung-colonization assay, as many
(REFS 80,81) (FIG. 4). We have demonstrated both mathe- as 105 lung cancer cells are injected into mouse tail veins,
matically and empirically that intratumoral acidosis but fewer than 100 cells generally survive to form
results in diffusion of H+ ions along concentration gradi- colonies. Cells pre-treated with hypoxia for 24 hours are
ents into peritumoral normal tissue32. Normal cells, four times more likely to survive than their normoxic
which lack a mechanism to adapt to extracellular acidosis counterparts93. Although there are other possible inter-
(such as a p53 mutation) are unable to survive under pretations of these data, we suggest that they support the
such conditions, whereas the tumour populations con- hypothesis that the glycolytic phenotype contributes to
tinue to proliferate. In addition, acidosis itself can be the efficiency of metastasis by allowing cells to survive
mutagenic and CLASTOGENIC82, possibly through inhibition transient hypoxia.
of DNA repair (for a review, see REF. 80) and can lead to
both inhibition of GAP-JUNCTION conductance and to spon- Summary and future directions
taneous transformation of normal diploid fibroblasts83. In summary, we suggest that upregulation of glycolytic
The resulting phenotypic diversity enhances the evolu- metabolic pathways in the vast majority of invasive can-
tionary potential of the tumour population, which cers is the result of adaptation to consistent environmen-
accelerates malignant progression and adaptation to ther- tal pressures in pre-malignant lesions, when diffusion
apeutic strategies34 (BOX 1). Finally, under some (but not limitations result in gradients of hypoxia and acidosis.
all) conditions, low pH stimulates in vitro invasion84 and Cellular traits selected by these conditions include con-
in vivo metastasis85. The mechanisms of such induction stitutive upregulation of glycolysis and resistance to acid-
induced apoptosis. Mathematical models and empirical
observation indicate that the advantages conferred by
Box 1 | Consequences of hypoxia and acidosis this combination of phenotypic traits are both sufficient
As tumours evolve and become first hypoxic and then acidic, malignant progression is and necessary to promote unconstrained tumour prolif-
accelerated and resistance to therapeutic strategies occurs. For further information, eration. Furthermore, both mathematical models and
see REF. 36. empirical evidence indicate that diffusion of acid from
the tumour into peritumoral normal tissue provides a
Hypoxia Acidosis specific mechanism promoting tumour invasion32.
Radioresistance Increased radioresistance The crucial importance of the glycolytic phenotype is
Drug resistance Resistance to anthracyclines emphasized by studies demonstrating that increased glu-
Metastasis and invasion Increased metastases
cose uptake is observed to coincide with the transition
from pre-malignant lesions to invasive cancer94,95. These
Increased mutation rate Increased migration and invasion
evolutionary advantages explain the remarkable preva-
Gene expression induced by hypoxia- Mutagenesis/clastogenesis lence of the glycolytic phenotype in human cancers and
inducible factor
the otherwise puzzling observation that malignant cells
Apoptosis Apoptosis
remain glycolytic even in the presence of normoxia.
The molecular basis for evolution of the glycolytic relationship and timing between the angiogenic
phenotype has been clarified by recent advances in switch and the glycolytic switch? Can pharmacologi-
understanding the HIF system, but much additional cal agents be developed to inhibit emergence of the
work will be required to fully understand the complex glycolytic/acidic phenotype and, therefore, retard the
pathways involved in hypoxic response, metabolic con- progression in early lesions? Would alteration in sys-
trols and adaptation to acidosis in cancer progression. temic pH perturb tumour growth dynamics and con-
Despite gaps in our knowledge, the glycolytic pheno- fer relative resistance to tumour development? Finally,
type could be exploited for treatment at several levels. would local or systemic alteration of buffering capac-
As this phenotype emerges early in carcinogenesis, it ity and balance of extracellular tumour pH reverse the
might represent a possible target in cancer prevention. aggressive tumour phenotype in the absence of any
At later stages, a more complete understanding of the other change? On this last point, we have tantalizing
molecular and physiological consequences might lead evidence that mild renal failure which is typically
to targeted therapies. accompanied by systemic acidosis is associated
Finally, this model of carcinogenesis indicates new with improved prognosis in patients with metastatic
avenues of investigation. For example, what is the renal cancer following nephrectomy 96.
1. Bernards, R. & Weinberg, R. A. A progression puzzle. 15. Artemov, D., Bhujwalla, Z. M., Pilatus, U. & Glickson, J. D. Demonstrates the annulus of tissues that can be
Nature 418, 823 (2002). Two-compartment model for determination of glycolytic oxygenated by a single capillary.
A compelling opinion piece, in which the authors rates of solid tumors by in vivo 13C NMR spectroscopy. NMR 28. Thomlinson, R. H. & Gray, L. H. The histological structure of
convincingly argue that the molecular phenotypes of Biomed. 11, 395404 (1998). some human lung cancers and the possible implications for
metastatic cancers arose early during 16. Mathupala, S. P., Rempel, A. & Pedersen, P. L. Aberrant radiotherapy. Br. J. Cancer 9, 539549 (1955).
carcinogenesis. Although somatic evolution is implied glycolytic metabolism of cancer cells: a remarkable Documents that necrosis in tumours occurs at
in this work, the environmental nature of the selection coordination of genetic, transcriptional, post-translational, distances from blood vessels and that this was
pressures are not discussed. and mutational events that lead to a critical role for type II consistent with the oxygen diffusion distances.
2. Racker, E. History of the Pasteur effect and its pathobiology. hexokinase. J. Bioenerg. Biomembr. 29, 339343 (1997). 29. Dewhirst, M. W., Secomb, T. W., Ong, E. T., Hsu, R. &
Mol. Cell. Biochem. 5, 1723 (1974). Provides a cogent argument for the role of Gross, J. F. Determination of local oxygen consumption
3. Warburg, O. Ueber den stoffwechsel der tumoren. hexokinase in regulating glycolytic flux and its rates in tumors. Cancer Res. 54, 33333336 (1994).
(Constable, London, 1930). regulation by oncogenes and subcellular 30. Helmlinger, G., Yuan, F., Dellian, M. & Jain, R. K. Interstitial
4. Semenza, G. L. et al. The metabolism of tumours: 70 years localization. pH and pO2 gradients in solid tumors in vivo: high-resolution
later. Novartis Found. Symp. 240, 251260 (2001). 17. Kunkel, M. et al. Overexpression of Glut-1 and increased measurements reveal a lack of correlation. Nature Med. 3,
In this timely review, Semenza describes the relation glucose metabolism in tumors are associated with a poor 177182 (1997).
between HIF1 and the regulation of glycolysis. prognosis in patients with oral squamous cell carcinoma. Despite its title, this very well conducted study
5. Weinhouse, S. The Warburg hypothesis fifty years later. Cancer 97, 10151024 (2003). documents the correlation between pH and
Z. Krebsforsch. Klin. Onkol. Cancer Res. Clin. Oncol. 87, This careful study is one of many that document the oxygenation as they decrease with distances from
115126 (1976). diagnostic importance of GLUT1 and glycolysis in feeding capillaries.
6. Hawkins, R. A. & Phelps, M. E. PET in clinical oncology. carcinomas. 31. Graeber, T. G. et al. Hypoxia-mediated selection of cells with
Cancer Metastasis Rev. 7, 119142 (1988). 18. Mochiki, E. et al. Evaluation of 18F-2-deoxy-2-fluoro-D- diminished apoptotic potential in solid tumours. Nature 379,
7. Weber, W. A., Avril, N. & Schwaiger, M. Relevance of glucose positron emission tomography for gastric cancer. 8891 (1996).
positron emission tomography (PET) in oncology. World J. Surg. 28, 247253 (2004). Documents the somatic evolutionary pressure
Strahlenther. Onkol. 175, 356373 (1999). 19. Postovit, L. M., Adams, M. A., Lash, G. E., Heaton, J. P. & mediated by hypoxia.
8. Gambhir, S. S. Molecular imaging of cancer with positron Graham, C. H. Oxygen-mediated regulation of tumor cell 32. Gatenby, R. A. & Gawlinski, E. T. A reaction-diffusion model
emission tomography. Nature Rev. Cancer 2, 683693 (2002). invasiveness. Involvement of a nitric oxide signaling of cancer invasion. Cancer Res. 56, 57455753 (1996).
A well written review on FdG PET imaging. pathway. J. Biol. Chem. 277, 3573035737 (2002). Mathematical methods and empirical evidence were
9. Czernin, J. & Phelps, M. E. Positron emission tomography 20. He, X. et al. Hypoxia increases heparanase-dependent used to demonstrate the acid-induced tumour-
scanning: current and future applications. Annu. Rev. Med. tumor cell invasion, which can be inhibited by invasion model for the first time.
53, 89112 (2002). antiheparanase antibodies. Cancer Res. 64, 39283933 33. Gatenby, R. A. & Vincent, T. L. An evolutionary model of
A comprehensive review of extant literature. The (2004). carcinogenesis. Cancer Res. 63, 62126220 (2003).
authors convincingly document the very high 21. Buchler, P. et al. Hypoxia-inducible factor 1 regulates The formal mathematical development of evolutionary
sensitivity and specificity of FdG PET in diagnosing vascular endothelial growth factor expression in human game theory in carcinogenesis.
and staging diverse types of metastatic cancers. pancreatic cancer. Pancreas 26, 5664 (2003). 34. Fearon, E. R. & Vogelstein, B. A genetic model for colorectal
10. Bos, R. et al. Biologic correlates of 18fluorodeoxyglucose 22. Postovit, L. M., Adams, M. A., Lash, G. E., Heaton, J. P. & tumorigenesis. Cell 61, 759767 (1990).
uptake in human breast cancer measured by positron Graham, C. H. Nitric oxide-mediated regulation of hypoxia- Introduced the molecular genetic changes that occur
emission tomography. J.Clin.Oncol. 20, 379387 (2002). induced B16F10 melanoma metastasis. Int. J. Cancer 108, during gastrointestinal carcinogenesis and discussed
This well-conducted study quantitatively analysed the 4753 (2004). the concept of clonal outgrowth in this context. There
molecular phenotypes of tumours that had either high 23. Krtolica, A. & Ludlow, J. W. Hypoxia arrests ovarian was no discussion of environmental selection
or low rates of FdG trapping. carcinoma cell cycle progression, but invasion is unaffected. pressures.
11. Burt, B. M. et al. Using positron emission tomography with Cancer Res. 56, 11681173 (1996). 35. Chresand, T. J., Gillies, R. J. & Dale, B. E. Optimum fiber
[18F]FDG to predict tumor behavior in experimental 24. Schornack, P. A. & Gillies, R. J. Contributions of cell spacing in a hollow fiber bioreactor. Biotechnol. Bioeng. 32,
colorectal cancer. Neoplasia (New York) 3, 189195 (2001). metabolism and H+ diffusion to the acidic pH of tumors. 983992 (1988).
12. Schilling, C. H., Schuster, S., Palsson, B. O. & Heinrich, R. Neoplasia (New York) 5, 135145 (2003). 36. Secomb, T. W. et al. Theoretical simulation of oxygen
Metabolic pathway analysis: basic concepts and scientific Determined proton production rates in breast cancer transport to tumors by three-dimensional networks of
applications in the post-genomic era. Biotechnol. Prog. 15, lines with low and high metastatic capability, and microvessels. Adv. Exp. Med. Biol. 454, 629634 (1998).
296303 (1999). related these to glycolytic rate. These rates were used 37. Wykoff, C. C. et al. Expression of the hypoxia-inducible
13. Dang, C. V., Lewis, B. C., Dolde, C., Dang, G. & Shim, H. in a reactiondiffusion model to predict steady-state and tumor-associated carbonic anhydrases in ductal
Oncogenes in tumor metabolism, tumorigenesis, and tumour pH values. carcinoma in situ of the breast. Am. J. Pathol. 158,
apoptosis. J. Bioenerg. Biomembr. 29, 345354 (1997). 25. Griffiths, J. R., McIntyre, D. J., Howe, F. A. & Stubbs, M. 10111019 (2001).
One of many papers in this issue of the Journal of Why are cancers acidic? A carrier-mediated diffusion model This work shows, with histopathology, the expression
Bioenergetics and Biomembranes that dealt with the for H+ transport in the interstitial fluid. Novartis Found. Symp. of CA IX and CA XII in carcinoma in situ lesions. These
molecular controls of glucose metabolism. In this 240, 4662 (2001). two carbonic anhydrases are sensitive to hypoxia and
review, primary data were presented to support the 26. Bhujwalla, Z. M. et al. Combined vascular and extracellular these data are consistent with significant hypoxia in
importance and molecular controls of the glucose pH imaging of solid tumors. NMR Biomed. 15, 114119 in situ lesions.
transporter and its regulation by MYC. (2002). 38. Kimura, H. et al. Fluctuations in red cell flux in tumor
14. Rivenzon-Segal, D., Boldin-Adamsky, S., Seger, D., Seger, R. Used spectroscopic imaging to measure the spatial microvessels can lead to transient hypoxia and
& Degani, H. Glycolysis and glucose transporter 1 as variations in tumour pH, and these were related to reoxygenation in tumor parenchyma. Cancer Res. 56,
markers of response to hormonal therapy in breast cancer. vascular perfusion measures in the same tumours. 55225528 (1996).
Int. J. Cancer 107, 177182 (2003). 27. Krogh, A. The number and distribution of capillaries in 39. Hill, R. P., De Jaeger, K., Jang, A. & Cairns, R. pH, hypoxia
One of many papers that demonstrates the important muscles with calculations of the oxygen pressure head and metastasis. Novartis Found. Symp. 240, 154165 (2001).
role of the glucose transporter in regulating glycolytic necessary for supplying the tissue. J. Physiol. 52, 409415 40. Gilead, A. & Neeman, M. Dynamic remodeling of the
flux. (1919). vascular bed precedes tumor growth: MLS ovarian
carcinoma spheroids implanted in nude mice. Neoplasia 60. Carmeliet, P. et al. Role of HIF-1 in hypoxia-mediated 82. Morita, T., Nagaki, T., Fukuda, I. & Okumura, K.
(New York) 1, 226230 (1999). apoptosis, cell proliferation and tumour angiogenesis. Clastogenicity of low pH to various cultured mammalian
41. Baudelet, C. et al. Physiological noise in murine solid tumors Nature 394, 485490 (1998). cells. Mutat. Res. 268, 297305 (1992).
using T2*-weighted gradient echo imaging: a marker for 61. Robey, I., Lien, A., Welsh, S., Baggett, B. & Gillies, R. J. 83. Ruch, R. J., Klaunig, J. E., Kerckaert, G. A. & LeBoeuf, R.
tumor acute hypoxia? Phys. Med. Biol. 49, 33893411 HIF-1 and the glycolytic phenotype in tumors. Neoplasia (in A. Modification of gap junctional intercellular communication
(2004). the press). by changes in extracellular pH in syrian hamster embryo
42. Braun, R. D., Lanzen, J. L. & Dewhirst, M. W. Fourier 62. Lu, H., Forbes, R. A. & Verma, A. Hypoxia-inducible factor 1 cells. Carcinogenesis 11, 909913 (1990).
analysis of fluctuations of oxygen tension and blood flow in activation by aerobic glycolysis implicates the Warburg 84. Martinez-Zaguilan, R. et al. Acidic pH enhances the invasive
R3230Ac tumors and muscle in rats. Am. J. Physiol. 277, effect in carcinogenesis. J. Biol. Chem. 277, 2311123115 behavior of human melanoma cells. Clin. Exp. Metastasis
H551H568 (1999). (2002). 14, 176186 (1996).
43. Dewhirst, M. W. et al. Microvascular studies on the origins of 63. Semenza, G. Targeting HIF-1 for cancer therapy. Nature 85. Schlappack, O. K., Zimmermann, A. & Hill, R. P. Glucose
perfusion-limited hypoxia. Br. J. Cancer Suppl. 27, Rev. Cancer 3, 113 (2003). starvation and acidosis: effect on experimental metastasic
S247S251 (1996). References 5863 describe the role of HIF1 in potential, DNA content and MTX resistance of murine
44. Sonveaux, P. et al. Endothelin-1 is a critical mediator of regulating aerobic and anaerobic glycolysis. tumour cells. Br. J. Cancer 64, 663670 (1991).
myogenic tone in tumor arterioles: implications for cancer 64. Semenza, G. Signal transduction to hypoxia-inducible factor 1. 86. Rozhin, J., Sameni, M., Ziegler, G. & Sloane, B. F. Pericellular
treatment. Cancer Res. 64, 32093214 (2004). Biochem. Pharmacol. 64, 993998 (2002). pH affects distribution and secretion of cathepsin B in
45. Patan, S. et al. Vascular morphogenesis and remodeling in a 65. Welsh, S. J., Bellamy, W. T., Briehl, M. M. & Powis, G. malignant cells. Cancer Res. 54, 65176525 (1994).
human tumor xenograft: blood vessel formation and growth The redox protein thioredoxin-1 (Trx-1) increases hypoxia- 87. Montcourrier, P., Silver, I., Farnoud, R., Bird, I. & Rochefort, H.
after ovariectomy and tumor implantation. Circ. Res. 89, inducible factor 1 protein expression: Trx-1 overexpression Breast cancer cells have a high capacity to acidify
732739 (2001). results in increased vascular endothelial growth factor extracellular milieu by a dual mechanism. Clin. Exp.
46. Kiani, M. F., Pries, A. R., Hsu, L. L., Sarelius, I. H. & Cokelet, G. R. production and enhanced tumor angiogenesis. Cancer Res. Metastasis 15, 382392 (1997).
Fluctuations in microvascular blood flow parameters caused 62, 50895095 (2002). 88. Brizel, D. M. et al. Elevated tumor lactate concentrations
by hemodynamic mechanisms. Am. J. Physiol. 266, 66. Moeller, B. J., Cao, Y., Li, C. Y. & Dewhirst, M. W. Radiation predict for an increased risk of metastases in head-and-neck
H1822H1828 (1994). activates HIF-1 to regulate vascular radiosensitivity in cancer. Int. J. Radiat. Oncol. Biol. Phys. 51, 349353 (2001).
References 3846 document the periodic nature of tumors: role of reoxygenation, free radicals, and stress 89. Walenta, S. et al. High lactate levels predict likelihood of
tumour oxygenation. granules. Cancer Cell 5, 429441 (2004). metastases, tumor recurrence, and restricted patient survival
47. Park, H. J., Lyons, J. C., Ohtsubo, T. & Song, C. W. Acidic 67. Seagroves, T. et al. Transcription Factor HIF-1 is a necessary in human cervical cancers. Cancer Res. 60, 916921 (2000).
environment causes apoptosis by increasing caspase mediator of the Pasteur effect in mammalian cells. Mol. Cell. 90. Ito, S. et al. Coexpression of glucose transporter 1 and
activity. Br. J. Cancer 80, 18921897 (1999). Biol. 21, 34363444 (2001). matrix metalloproteinase-2 in human cancers. J. Natl
48. Williams, A. C., Collard, T. J. & Paraskeva, C. An acidic 68. Brand, K. Aerobic glycolysis by proliferating cells: protection Cancer Instit. 94, 10801091 (2002).
environment leads to p53 dependent induction of apoptosis against oxidative stress at the expense of energy yield. 91. Al Mehdi, A. B. et al. Intravascular origin of metastasis from
in human adenoma and carcinoma cell lines: implications for J. Bioenerg. Biomembr. 29, 355364 (1997). the proliferation of endothelium-attached tumor cells: a new
clonal selection during colorectal carcinogenesis. Oncogene 69. Osthus, R. C. et al. Deregulation of glucose transporter 1 model for metastasis. Nature Med. 6, 100102 (2000).
18, 31993204 (1999). and glycolytic gene expression by c-Myc. J. Biol. Chem. A watershed paper describing the
49. Shrode, L. D., Tapper, H. & Grinstein, S. Role of intracellular 275, 2179721800 (2000). microenvironmental behaviour of lung metastases
pH in proliferation, transformation, and apoptosis. 70. Noguchi, Y. et al. Expression of facilitative glucose transporter 1 using a novel microscopy method. This paper
J. Bioenerg. Biomembr. 29, 393399 (1997). mRNA in colon cancer was not regulated by k-ras. Cancer challenges the paradigm that extravasation is a
References 4749 deal with pH-induced apoptosis. Letters 154, 137142 (2000). necessary component of the metastasis programme.
Grinsteins review concludes that cytoplasmic 71. Chen, C., Pore, N., Behrooz, A., Ismail-Beigi, F. & Maity, A. 92. Wong, C. W. et al. Intravascular location of breast cancer
acidification is unlikely to be part of the apoptosis Regulation of glut1 mRNA by hypoxia-inducible factor-1. cells after spontaneous metastasis to the lung. Am. J.
paradigm, but that externally lowered pH might Interaction between H-ras and hypoxia. J. Biol. Chem. 276, Pathol. 161, 749753 (2002).
promote apoptotic cell death. 95199525 (2001). 93. Rofstad, E. K. & Danielsen, T. Hypoxia-induced metastasis
50. Lee, A. H. & Tannock, I. F. Heterogeneity of intracellular pH 72. Mathupala, S. P., Heese, C. & Pedersen, P. L. Glucose of human melanoma cells: involvement of vascular
and of mechanisms that regulate intracellular pH in catabolism in cancer cells. The type II hexokinase promoter endothelial growth factor-mediated angiogenesis. Br. J.
populations of cultured cells. Cancer Res. 58, 19011908 contains functionally active response elements for the Cancer 80, 16971707 (1999).
(1998). tumor suppressor p53. J. Biol. Chem. 272, 2277622780 Provides clear evidence that pretreatment with acute
51. Ober, S. S. & Pardee, A. B. Intracellular pH is increased after (1997). hypoxia can increase the efficiency of metastasis.
transformation of Chinese hamster embryo fibroblasts. 73. Goel, A., Mathupala, S. P. & Pedersen, P. L. Glucose 94. Younes, M., Lechago, L. V. & Lechago, J. Overexpression of
Proc. Natl Acad. Sci. USA 84, 27662770 (1987). metabolism in cancer. Evidence that demethylation events the human erythrocyte glucose transporter occurs as a late
52. McLean, L. A., Roscoe, J., Jorgensen, N. K., Gorin, F. A. & play a role in activating type II hexokinase gene expression. event in human colorectal carcinogenesis and is associated
Cala, P. M. Malignant gliomas display altered pH regulation J. Biol. Chem. 278, 1533315340 (2003). with an increased incidence of lymph node metastases.
by NHE1 compared with nontransformed astrocytes. Am. J. 74. Gillies, R. J., Martinez-Zaguilan, R., Martinez, G. M., Clin. Cancer Res. 2, 11511154 (1996).
Physiol. 278, C676C688 (2000). Serrano, R. & Perona, R. Tumorigenic 3T3 cells maintain 95. Yasuda, S. et al. 18F-FDG PET detection of colonic
53. Martinez-Zaguilan, R., Lynch, R. M., Martinez, G. M. & an alkaline intracellular pH under physiological conditions. adenomas. J. Nucl. Med. 42, 989992 (2001).
Gillies, R. J. Vacuolar type proton ATPases are functionally Proc. Natl Acad. Sci. USA 87, 74147418 (1990). 96. Gatenby, R. A., Gawlinski, E. T., Tangen, C. M., Flanigan, R. C.
expressed in the plasma membranes of human tumor cells. 75. Reshkin, S. J. et al. Na/H exchanger-dependent intracellular & Crawford, E. D. The possible role of postoperative
Am. J. Physiol. 265, c1015c1029 (1993). alkalinization is an early event in malignant transformation azotemia in enhanced survival of patients with metastatic
References 5053 describe mechanisms of pH and play an essential role in the development of subsequent renal cancer after cytoreductive nephrectomy. Cancer Res.
regulation that are documented to be upregulated in transformation-associated phenotypes. FASEB J. 14, 62, 52185222 (2002).
cancers. 21852197 (2000).
54. Gottlieb, R. A., Giesing, H. A., Zhu, J. Y., Engler, R. L. & 76. Li, X. et al. Relationship of MR-derived lactate, mobile lipids Acknowledgements
Babior, B. M. Cell acidification in apoptosis: granulocyte and relative blood volume for in vivo gliomas. Am. J. We wish to acknowledge the invaluable contributions of
colony-stimulating factor delays programmed cell death Neuroradiol. (in the press). E. Gawlinski and T. Vincent for their efforts in the mathematical
in neutrophils by up-regulating the vacuolar H+-ATPase. Describes the observation of increased lactate in non- modelling that led to the insights presented here. We also thank
Proc. Natl Acad. Sci. USA 92, 59655968 (1995). enhancing grade III gliomas, indicating that metabolic E. Racker for stimulating this research by posing to us the question
Demonstrates that vacuolar H+-ATPase activity is upregulation might precede angiogenesis. in the title.
anti-apoptotic. 77. Nelson, S. J. Multivoxel magnetic resonance
55. Younes, M., Ertan, A., Lechago, L. V., Somoano, J. & spectroscopy of brain tumors. Mol. Cancer Ther. 2, Competing interests statement
Lechago, J. Human erythrocyte glucose transporter 497507 (2003). The authors declare no competing financial interests.
(Glut1) is immunohistochemically detected as a late 78. Dafni, H., Landstrom, L., Schechter, B., Kohen, F. &
event during malignant progression in Barretts Neeman, M. MRI and fluorescence microscopy of the acute
metaplasia. Cancer Epidemiol. Biomarkers Prev. 6, vascular response to VEGF165: vasodilation, hyper- Online links
303305 (1997). permeability and lymphatic uptake, followed by rapid
56. Sakashita, M. et al. Glut1 expression in T1 and T2 stage inactivation of the growth factor. NMR Biomed. 15, 120131 DATABASES
colorectal carcinomas: its relationship to clinicopathological (2002). The following terms in this article are linked online to:
features. Eur. J. Cancer 37, 204209 (2001). 79. Hanahan, D. & Folkman, J. Patterns and emerging National Cancer Institute: http://cancer.gov/
57. Grover-McKay, M., Walsh, S. A., Seftor, E. A., Thomas, P. mechanisms of the angiogenic switch during tumorigenesis. breast cancer | cervical cancer | colon cancer | gastric cancer |
A. & Hendrix, M. J. Role for glucose transporter 1 protein in Cell 86, 353364 (1996). head and neck cancer | oesophageal cancer
human breast cancer. Pathol. Oncol. Res. 4, 115120 80. Raghunand, N., Gatenby, R. A. & Gillies, R. J. Entrez Gene:
(1998). Microenvironmental and cellular consequences of altered http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene
58. Semenza, G. L. Hypoxia-inducible factor 1: master regulator blood flow in tumors. Br. J. Radiol. 77, S11S22 (2004). caspase-3 | GLUT1 | GLUT3 | HRAS | HIF1 | KRAS | MYC | p53 |
of O2 homeostasis. Curr. Opin. Genet. Dev. 8, 588594 81. Gillies, R. J., Raghunand, N., Karczmar, G. & Bhujwalla, Z. VEGF | VHL
(1998). MR Imaging of the tumor microenvironment. J. Magn.
59. Yasuda, S. et al. Hexokinase II and VEGF expression in liver Reson. Imaging 16, 430450 (2002). FURTHER INFORMATION
tumors: correlation with hypoxia-inducible factor 1 and its A comprehensive review describing MRI of clinical DMetrix digital imaging program: www.dmetrix.com
significance. J. Hepatol. 40, 117123 (2004). and experimental tumours. Access to this interactive links box is free online.